Sydbank analyst: GSK news could help Bavarian Nordic in partner hunt

GSK has released positive data for its RSV vaccine, and according to Søren Løntoft Hansen, senior analyst at Sydbank, this could rub off positively on Bavarian’s partner search.
Photo: Philip Davali/Ekstra Bladet, Philip Davali
Photo: Philip Davali/Ekstra Bladet, Philip Davali
by marketwire, translated by catherine brett

Bavarian Nordic is on the hunt for a partner to collaborate with on its RSV vaccine, and according to senior analyst at Sydbank Søren Løntoft Hansen, that hunt may just have got easier.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading